Skip to main content
. 2020 Mar 18;11:139. doi: 10.3389/fendo.2020.00139

Table 3.

Percentage of subjects with hyperglycemia and dyslipidemia among those with differential expressions of serum TPOAb and TgAb.

TPOAbTgAb TPOAb+TgAb TPOAbTgAb+ TPOAb+TgAb+
MEN
N (%) 4,000 (68.9) 800 (13.8) 491 (8.5) 511 (8.8)
Central obesity 1,719 (43.0) 329 (41.1) 213 (43.4) 222 (43.4)
Hypertension 1,596 (39.9) 335 (41.9) 180 (36.7) 202 (39.5)
HYPERGLYCEMIA
IFG 553 (13.8) 104 (13.0) 50 (10.2)a 66 (12.9)
IGT 282 (7.0) 61 (7.6) 37 (7.5) 41 (8.0)
Pre-diabetes 1,601 (40.0) 319 (39.9) 195 (39.7) 203 (39.7)
Diabetes 599 (15.0) 134 (16.8) 84 (17.1) 75 (14.7)
DYSLIPIDEMIA
High TG 1,432 (35.8) 297 (37.1) 170 (34.6) 188 (36.8)
High TC 1,273 (31.8) 266 (33.3) 164 (33.4) 162 (31.7)
High LDL-C 1,007 (25.2) 215 (26.9) 124 (25.3) 136 (26.6)
Low HDL-C 602 (15.0) 126 (15.8) 76 (15.5) 77 (15.1)
WOMEN
N (%) 8,000 (65.8) 1,202 (9.9) 1,588 (12.0) 1,372 (11.3)
Central obesity 2,616 (32.7) 388 (32.3) 502 (31.6) 443 (32.3)
Hypertension 2,214 (27.7) 361 (30.0) 423 (26.6) 359 (26.2)
HYPERGLYCEMIA
IFG 742 (9.3) 107 (8.9) 149 (9.4) 120 (8.7)
IGT 685 (8.6) 112 (9.3) 111 (7.0)b 108 (7.9)
Pre-diabetes 2,927 (36.6) 476 (39.6) 554 (34.9) 499 (36.4)
Diabetes 958 (12.0) 142 (11.8) 169 (10.6) 147 (10.7)
DYSLIPIDEMIA
High TG 1,903 (23.8) 276 (23.0) 341 (21.5)c 311 (22.7)
High TC 2,505 (31.3) 414 (34.4)d 490 (30.9) 412 (30.0)
High LDL-C 1,676 (21.0) 275 (22.9) 356 (22.4) 298 (21.7)
Low HDL-C 2,195 (27.4) 310 (25.8) 420 (26.4) 383 (27.9)

Data are presented as n (%).

a

P = 0.026,

b

P = 0.038,

c

P = 0.047,

d

P = 0.03 as compared with that of TPOAbTgAb group, and none of them was less than the adjusted cutoff value of P due to the multiple comparisons for statistical significance (0.05/3 = 0.017) in chi-square test.